Endovascular, Outpatient CFA Treatment

Robert Feldman, MD

Severely calcified right common femoral lesion. Patient considered high-surgical risk due to previous infection on contralateral side. Channel initially created using rotablator, followed by delivery of 6.0 x 60mm Shockwave IVL. No further device treatment. Final angiogram demonstrates no gradient and no complications

We use cookies to provide you with the best experience on our website. Please consult our Privacy Policy to learn more about the cookies we use and how you can block them. By continuing on this website, you agree to the use of cookies.

We're excited about IVL's potential in aortic stenosis, too!

But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.

Get Crackin with Shockwave IVL Today

Thanks for contacting us! We will get in touch with you shortly.

Wow - you're ready to start cracking, aren't you?

Too bad our coronary technology is not yet approved in the United States. Good news is that we have initiated our U.S. FDA IDE study. Learn more about the Disrupt CAD III study on our clinical research portion of the website.